Pyxis Oncology Strengthens Board of Directors

NEXT STORY
Motus GI Announces Enrollment of Patients at Second Site in the European Union Outpatient Study of the Pure-Vu® System
PREV STORY
Women’s Health Diagnostics Market Research Report by Application, by Type, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Esperion Announces Publication of Rationale and Design of Landmark CLEAR Cardiovascular Outcomes Trial Evaluating NEXLETOL® (bempedoic acid) Tablet in American Heart Journal

author_avatar
NASDAQ Market News

miRagen Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update

New MRG-106 Phase 1 cutaneous T-cell lymphoma clinical trial data releasedExpansion of the MRG-106 ...

author_avatar
NASDAQ Market News

Tiziana Life Sciences Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program

author_avatar
NASDAQ Market News